Gosselies, Belgium

Clotilde Hoyos

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Iteos Belgium Sa. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clotilde Hoyos. Retrieved from https://idiyas.com/inventor/clotilde-hoyos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clotilde Hoyos: Innovator in Antibody Research

Introduction

Clotilde Hoyos is a prominent inventor based in Gosselies, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work is recognized for its potential impact on medical research and therapeutic applications.

Latest Patents

Clotilde holds a patent for "ANTI-TREM2 ANTIBODIES AND METHODS OF USE." This patent represents her innovative approach to addressing challenges in the medical field, particularly related to neurodegenerative diseases.

Career Highlights

Clotilde is currently employed at Iteos Belgium SA, where she continues to advance her research and development efforts. Her dedication to innovation has positioned her as a key figure in her organization and the broader scientific community.

Collaborations

Throughout her career, Clotilde has collaborated with talented individuals such as Catherine Hoofd and Thibaut Janss. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research.

Conclusion

Clotilde Hoyos is a trailblazer in the field of antibody research, with a focus on developing innovative solutions for medical challenges. Her contributions and collaborations highlight her commitment to advancing science and improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…